This was 2 weeks ago
LocationOnline
ProgrammesThe European Partnership for Personalised Medicine has just launched a new opportunity for start-ups, researchers and early-stage teams working on cutting-edge solutions in personalised medicine.
EP PerMed Fast Track Validation Programme has been designed to address a key challenge in the development of personalised medicine (PM) solutions: the validation phase. Transitioning innovative concepts into market-ready products requires thorough validation to ensure they align with the needs and expectations of end-users, including clinicians and patients.
The Fast Track Validation Programme provides a structured and accelerated pathway for PM innovators to successfully validate their solutions. In this webinar, EP PerMed will offer an overview of the programme, its requirements, and the application and support process, providing key insights for those interested in applying.
More information and registration here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.
ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.